RS

Rupali Singh

Active Director Director DIN 02876674
DIN 02876674 First appointment Aug 2023 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2023
Shareholding value •••• Premium profile

About Rupali Singh

Data last updated:

Rupali Singh is a Director at Surya Pharma & Ayurvedic Private Limited (since 2023). The company operates in Healthcare. Surya Pharma & Ayurvedic Private Limited reported revenue of ₹3.98 Cr (FY 2024).

DIN 02876674
Primary Designation Director
Industry Healthcare
First Appointment 01 Aug 2023
Oldest Company Age 13 yrs
Largest company Surya Pharma & Ayurvedic Private Limited · ₹3.98 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Aug 20232013₹3.98 Cr (FY 2024)Active

Board colleagues of Rupali Singh

Directorship timeline

Open interactive timeline →
Surya Pharma & Ayurvedic Private Limited
Premium access

Shareholding and investment profile for Rupali Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rupali Singh

Rupali Singh currently holds 1 directorship: Surya Pharma & Ayurvedic Private Limited (Director, since 01 Aug 2023, revenue ₹3.98 Cr (FY 2024)).

Rupali Singh was first appointed on 01 Aug 2023 as Director at Surya Pharma & Ayurvedic Private Limited.

The current boards of Rupali Singh's companies include Kirti Singh (Surya Pharma & Ayurvedic Private Limited), Ram Kumar Singh (Surya Pharma & Ayurvedic Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available